Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial [Thoracic Oncology]

Conclusion LMWH did not improve overall survival in the patients with lung cancer in this trial. A significant reduction in VTE is associated with an increase in clinically relevant nonmajor bleeding. Strategies to target those at greatest risk of VTE are warranted.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Tags: Supportive Care, Supportive Care, Combined Modality Thoracic Oncology Source Type: research